Incidence and long-term outcomes of upper limb deep vein thrombosis associated with intracardiac devices: analysis of bleeding, recurrence, and sequelae.

Autor: Lago-Rodríguez MO; Venous Thromboembolism Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain., López-Rubio M; Venous Thromboembolism Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain. marinalopezrubio@outlook.com., Moragón-Ledesma S; Venous Thromboembolism Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.; Sanitary Research Institute Gregorio Marañón, Madrid, Spain., Oblitas CM; Venous Thromboembolism Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.; Sanitary Research Institute Gregorio Marañón, Madrid, Spain., Galeano-Valle F; Venous Thromboembolism Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.; Sanitary Research Institute Gregorio Marañón, Madrid, Spain., Atienza F; School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.; Sanitary Research Institute Gregorio Marañón, Madrid, Spain.; Department of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain., Carta A; Sanitary Research Institute Gregorio Marañón, Madrid, Spain.; Department of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Demelo-Rodríguez P; Venous Thromboembolism Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.; Sanitary Research Institute Gregorio Marañón, Madrid, Spain.
Jazyk: angličtina
Zdroj: Internal and emergency medicine [Intern Emerg Med] 2024 Oct; Vol. 19 (7), pp. 1959-1966. Date of Electronic Publication: 2024 Aug 08.
DOI: 10.1007/s11739-024-03710-8
Abstrakt: Pacemakers (PM) and implantable cardioverter-defibrillators are vital devices in contemporary clinical practice, but their growing adoption poses challenges. Complications, including lead migration, infections, and post-implantation venous thrombosis, underscore the importance of comprehensive investigation. This retrospective observational study enrolled patients diagnosed with upper limb deep vein thrombosis (DVT) secondary to intracardiac devices at a tertiary hospital from 2015 to 2022. The aim of the study was to determine the incidence and long-term outcomes (bleeding, DVT recurrence and sequelae) in these patients. Across the study period, 2681 intracardiac devices were implanted, with 12 cases of upper limb DVT documented. The majority of patients were male (91.7%), with a mean age of 63.92 years. DVT occurred in patients with PM (50%), implantable cardioverter-defibrillators (25%) and implantable cardioverter-defibrillators with Cardiac Resynchronization Therapy (25%). Treatment encompassed low-molecular-weight heparin (91.7%) during the acute episode and long-term anticoagulation with direct oral anticoagulants (75%) or vitamin K antagonists (25%). Over a mean follow-up period of 33.17 months, half of the patients exhibited long-term sequelae, notably collateral circulation (66.7%). Remarkably, no thrombosis recurrences were observed during follow-up. However, one patient (8.3%) experienced a major bleeding event during treatment, and one patient (8.3%) required device removal (PM) due to persistent symptoms. This study revealed upper limb DVT occurred in 0.45% of patients after intracardiac device implantation. Rate of thrombosis recurrence was low during follow-up. Although half of the patients developed long-term sequelae, the need for prolonged anticoagulant therapy in these cases remains uncertain.
(© 2024. The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI).)
Databáze: MEDLINE
Externí odkaz: